BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wolbink GJ, Schalkwijk C, Baars JW, Wagstaff J, van den Bosch H, Hack CE. Therapy with interleukin-2 induces the systemic release of phospholipase-A2. Cancer Immunol Immunother 1995;41:287-92. [PMID: 8536274 DOI: 10.1007/BF01517216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
Number Citing Articles
1 Ravandi A, Boekholdt SM, Mallat Z, Talmud PJ, Kastelein JJ, Wareham NJ, Miller ER, Benessiano J, Tedgui A, Witztum JL, Khaw KT, Tsimikas S. Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study. J Lipid Res 2011;52:1829-36. [PMID: 21821825 DOI: 10.1194/jlr.M015776] [Cited by in Crossref: 90] [Cited by in F6Publishing: 55] [Article Influence: 8.2] [Reference Citation Analysis]
2 Dong Z, Liu Y, Scott KF, Levin L, Gaitonde K, Bracken RB, Burke B, Zhai QJ, Wang J, Oleksowicz L, Lu S. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer. Carcinogenesis 2010;31:1948-55. [PMID: 20837598 DOI: 10.1093/carcin/bgq188] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
3 Oleksowicz L, Liu Y, Bracken RB, Gaitonde K, Burke B, Succop P, Levin L, Dong Z, Lu S. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer. Prostate 2012;72:1140-9. [PMID: 22127954 DOI: 10.1002/pros.22463] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kupert E, Anderson M, Liu Y, Succop P, Levin L, Wang J, Wikenheiser-brokamp K, Chen P, Pinney SM, Macdonald T, Dong Z, Starnes S, Lu S. Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules. BMC Cancer 2011;11:513. [PMID: 22151235 DOI: 10.1186/1471-2407-11-513] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
5 Zhou B, Xu H, Ni K, Ni X, Shen J. Expression of Chemokine XCL2 and CX3CL1 in Lung Cancer. Med Sci Monit 2016;22:1560-5. [PMID: 27156946 DOI: 10.12659/msm.895985] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
6 Nielen MM, van Schaardenburg D, Reesink HW, Twisk JW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Dijkmans BA. Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis. Ann Rheum Dis 2006;65:535-7. [PMID: 16079166 DOI: 10.1136/ard.2005.040659] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 4.9] [Reference Citation Analysis]
7 Su KP, Huang SY, Peng CY, Lai HC, Huang CL, Chen YC, Aitchison KJ, Pariante CM. Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biol Psychiatry 2010;67:550-7. [PMID: 20034614 DOI: 10.1016/j.biopsych.2009.11.005] [Cited by in Crossref: 114] [Cited by in F6Publishing: 112] [Article Influence: 8.8] [Reference Citation Analysis]